Rapid Dose Announces Closing of First Tranche of Common Share Private Placement
Rapid Dose Announces Closing of First Tranche of Common Share Private Placement
Burlington, Ontario--(Newsfile Corp. - July 22, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to announce that it has closed a first tranche of its previously announced equity private placement financing (the "Financing") for aggregate gross proceeds of $309,000.
Newsfile Corp.公司-2024年7月22日消息-快速剂量治疗公司(CSE:DOSE)(以下简称“RDT”或“公司”)非常高兴地宣布完成了先前宣布的股权定向增发融资(“融资”)的首期,总募集成功金额为309,000货币。
The proceeds of the Financing will be used for research and development, capital expansion, repayment of debt and general working capital requirements.
融资所得将用于研发、资本扩张、债务偿还以及一般经营资金需求。
The Financing allowed for a maximum of $6,000,000 of gross proceeds consisting of up to 35,294,117 common shares ("Common Shares") at a price of $0.17 per Common Share. On this first tranche closing, the Company issued 1,817,647 Common Shares at $0.17 per Common Share. Common Shares issued on the Financing will be subject to a four-month hold period from the date of closing in accordance with applicable securities laws.
融资允许最多募集6,000,000货币的总结余,包括每股价格为0.17美元的不超过35,294,117股普通股(“普通股”)。在本次首期交割时,公司以每股0.17美元的价格发行了1,817,647股普通股。融资中发行的普通股将根据适用的证券法规,自交割日起受到四个月的限售期限制。
About Rapid Dose Therapeutics Corp.
关于Rapid Dose Therapeutics Corp.是一种薄的,可口服溶解的电影,可以注入无限列表的活性成分,包括保健品、药品和疫苗,它们在迅速进入血液中,导致快速的活性成分。有关该公司的更多信息,请访问。
Rapid Dose Therapeutics is a Canadian biotechnology company revolutionizing drug delivery through innovation. The Company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient. For more information about the Company, visit .
快速剂量治疗是一家加拿大的生物技术公司,通过创新改变药物的传递方式。该公司的旗舰产品QuickStrip是一种薄的,可口服溶解的薄膜,可注入无限种活性成分,包括保健品、药品和疫苗,能够快速进入血液中,导致活性成分快速发挥作用。有关该公司的更多信息,请访问。
Contacts:
RDT Investor Contact:
Mark Upsdell, CEO
mupsdell@rapid-dose.com
416-477-1052
联系人:
马克·阿普斯德尔(Mark Upsdell),首席执行官
Mark Upsdell,首席执行官
416-477-1052
关于前瞻性声明的警示:
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS:
关于前瞻性声明的警告:本新闻稿包含前瞻性声明,包括预测、投影和预测。通常,但并非总是如此,前瞻性声明可以通过使用诸如“计划”、“计划”、“预计”或“不预期”、“持续”、“定期”、“估计”、“预测”、“意图”、“潜在”、“预计”、“不预计”或描述“目标”的单词或短语的变化或表明将采取某些行动、事件或结果“可能”、“可能”、“将”被采取、发生或实现。前瞻性声明涉及已知和未知的风险、未来事件、条件、不确定性和其他因素,它们可能导致实际结果、绩效或成就与任何未来结果、预测、投影、绩效或成就不同,这些结果、预测、投影、绩效或成就是前瞻性声明所表达的或暗示的。
Certain information in this news release may contain forward-looking information within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend", "will", "could", "are planned to", "are expected to" or the negative of these terms and similar expressions. Statements containing forward-looking information, including, without limitation, in this news release in particular, statements regarding the size and completion of the Financing and the use of proceeds from the Financing, and in general, in respect of the delivery of equipment and products using the QuickStrip product delivery method, the generation of recurring revenues, the plans, estimates, forecasts, projections, expectations or beliefs of RDT management as to future events or results, are believed to be reasonable based on information currently available to RDT management. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; termination of WLM agreements; future legislative and regulatory developments involving cannabis; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally, income tax and regulatory matters; the ability to implement its business strategies; competition; currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing list is not exhaustive. There can be no assurance that statements of forward-looking information, although considered reasonable by RDT management at the time of preparation, will prove to be accurate as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. Actual results and future events could differ materially from those anticipated in such forward-looking statements. Readers should not place undue reliance on forward-looking statements. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.
本新闻稿中的某些信息可能包含适用证券法规定的前瞻性信息。本新闻稿中包含的任何非历史事实陈述都可能被视为前瞻性陈述。前瞻性陈述通常由诸如“可能”、“应该”、“预计”、“期望”、“潜在”、“相信”、“打算”、“将会”、“可能”、“计划”、“预计”或这些词及类似表述的否定形式和类似表述组成。包含前瞻性信息的陈述,包括,但不限于,本新闻稿中的陈述,特别是关于融资的规模和完成情况以及融资所得款项的用途等方面,以及总体上涉及使用QuickStrip产品传递方法交付设备和产品、生成重复收入、RDt管理层对未来事件或结果的计划、估计、预测、预期或信念等方面,基于RDt管理层当前可获取的信息,被认为是合理的。前瞻性陈述必然涉及已知和未知的风险,包括但不限于与通货膨胀、行业不良事件、营销成本、市场损失、WLm协议终止、未来向大麻行业的立法和监管发展、无法从内部和外部来源获得足够的资本,和/或无法以有利条件获得足够的资本、加拿大大麻行业、所得税和监管事项、实施其业务策略的能力、竞争、货币和利率波动以及其他风险等方面有关的风险。读者应注意,上述列表并非详尽无遗。鉴于RDt管理层准备时认为包含前瞻性信息的陈述是合理的,因此不能保证前瞻性信息陈述的准确性,因为不能保证这些陈述所依赖的计划、意图或预期将会发生。实际结果和未来事件可能与这些前瞻性陈述所预期的不同。读者不应过多依赖前瞻性陈述。本新闻稿中包含的前瞻性陈述是截至本新闻稿发布日所作,公司明确声明不承担任何更新或更改包含任何前瞻性信息的声明或关于这些声明的因素或假设的义务,无论是因为获得新信息、未来事件或其他原因,除法律规定外。
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. This press release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities described herein in the United States. The securities described in this news release have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
本新闻稿不构成卖出或寻求买入证券的要约,任何可能在该行使,寻求或出售上述证券行为被视为非法。 本新闻稿不作为在美国卖出或寻求卖出所述证券的要约。 本新闻稿所述证券未在美国《证券法》或任何州证券法下注册,不得在美国境内或向美国人提供或销售,除非根据美国证券法和适用的州证券法进行注册或豁免。